Progyny, Inc.
NMS: PGNYLive Quote
📈 ZcoreAI Score
Our AI model analyzes Progyny, Inc.'s price action across multiple timeframes using regression channels and statistical scoring.
Get PGNY Z-Score →About Progyny, Inc.
Healthcare
Healthcare Plans
Progyny, Inc., a benefits management company, provides fertility, family building, and women's health benefits solutions in the United States. It offers fertility benefits solutions, such as differentiated benefits plan design that includes smart cycle treatment bundle; personalized concierge-style member support services; and a selective network of fertility specialists. The company also offers Progyny Rx, an integrated pharmacy benefits solution that provides access to the medications needed during their treatment and offers care management services, as well as pregnancy and postpartum, menopause and midlife, benefit and leave navigation, and parent and child wellbeing solutions. In addition, it provides assistance service program where various services can be offered through a reimbursement program, including adoption, surrogacy, doula, and travel reimbursement when travel is required to receive medical services. The company was formerly known as Auxogyn, Inc. and changed its name to Progyny, Inc. in 2015. Progyny, Inc. was incorporated in 2008 and is headquartered in New York, New York.
📊 Fundamental Analysis
Progyny, Inc. demonstrates a profit margin of 4.5%, which is below the sector average, suggesting competitive pressure.
The company recently reported 6.7% revenue growth, which is modest compared to its industry peers.
Return on Equity (ROE) is 12.5%, which suggests room for improvement in capital utilization.
At a current price of $16.30, PGNY currently trades near the bottom of its 52-week range (2%), indicating potential value or weakness (Range: $16.10 - $28.75).
💰 Valuation Insight
PGNY is valued broadly in line with the sector at a PE of 25.08. Analysts expect earnings growth, as indicated by a lower forward PE.
🏥 Financial Health
🔴
Profit Margin
Weak
✅
Debt/Equity
Excellent
🔴
Revenue Growth
Weak
🔴
Return on Equity
Weak
⚠️
Beta (Risk)
Moderate Volatility
Key Financials
Market Cap
$1.34B
Trailing P/E
25.08
Forward P/E
7.76
Beta (5Y)
0.99
52W High
$28.75
52W Low
$16.10
Avg Volume
1.52M
Day High
Day Low